LorindaChungMD

Rheumatology • Palo Alto, CA

Assistant Professor, Medicine - Immunology & Rheumatology, Stanford University Medical Center

Join to view full profile

Dr. Chung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chung's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94304
Phone+1 650-723-4000

Fax+1 650-849-1213

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2003 - 2006
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2003
Ohio State University College of MedicineClass of 2000

Certifications & Licensure

CA State Medical License 2001 - 2025
HI State Medical License 2003 - 2003
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACR) American College of Rheumatology

Clinical Trials

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
Completed
A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). Start of enrollment: 2008 Jun 01
Completed
Not Applicable
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Completed
Phase 2
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis Start of enrollment: 2015 Aug 01
Terminated
Phase 2
Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis Start of enrollment: 2016 Oct 01
Completed
Phase 2
KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2019 Jun 26
Terminated
Phase 2
A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2022 Nov 04
Recruiting
Phase 2
Roles: Principal Investigator
Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

41 citations
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
Sebastien Peytrignet, Christopher P. Denton, Mark Lunt, Roger Hesselstrand, Luc Mouthon
Rheumatology. 2018-02-01
10 citations
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi
Rheumatology. 2023-05-02
11 citations
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
Dinesh Khanna, Dinesh Khanna, Oliver Distler, Vincent Cottin, Kevin K Brown
Journal of Scleroderma and Related Disorders. 2022-10-01

Journal Articles

Clinical Significance of Autoantibodies in Dermatomyositis and Systemic Sclerosis
David F Fiorentino, Lorinda Chung, ScienceDirect
The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

Tocilizumab May Improve Lung Function in Early Systemic SclerosisFebruary 17th, 2021
Pregnancy Outcomes Worse with MyopathiesNovember 30th, 2017
Gene Activity Predicts Progression of Autoimmune Disease, Researchers FindDecember 22nd, 2016
Join now to see all

Professional Memberships

American College of Rheumatology - ACR
Fellow